Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia
NCT ID: NCT05073562
Last Updated: 2021-11-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2021-10-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nutrition+ Intervention
This group will receive a structured nutrition education package provided by Community Health Assistants (CHAs) based on a handbook on nutrition education developed by UNICEF with collaboration from the Liberia Ministry of Health. The structured nutrition education package will focus on four key areas: causes and prevention of anemia, healthy eating and food choices, hand washing, and physical exercise. Participants in the intervention group will also receive IFA supplementation on a weekly basis for the duration of the study, and a one-time oral deworming treatment (mebendazole), which will be administered once at the beginning of the study.
Iron and folic acid (IFA) supplementation
Weekly IFA supplementation for duration of the study.
Targeted nutrition education
Structured nutrition education package delivered at household level by trained Community Health Assistants (CHAs)
Mebendazole Pill
One-time deworming treatment with mebendazole.
Control group - standard services only
This group will receive only the current package of basic nutrition services provided at the health facility and at community level by health workers and CHAs, respectively.
Standard nutrition services
Basic nutrition services currently provided at the health facility and at community level in Liberia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iron and folic acid (IFA) supplementation
Weekly IFA supplementation for duration of the study.
Targeted nutrition education
Structured nutrition education package delivered at household level by trained Community Health Assistants (CHAs)
Mebendazole Pill
One-time deworming treatment with mebendazole.
Standard nutrition services
Basic nutrition services currently provided at the health facility and at community level in Liberia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lives within the selected study communities in Montserrado or Margibi counties
* Caregiver/adolescent consents to participate in the study
Exclusion Criteria
* Active malaria infection as defined by positive rapid diagnostic test (RDT)
* Severe acute malnutrition at the time of enrollment
* Known malignancy
* Known sickle cell disease
10 Years
19 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UNICEF
OTHER
Ministry of Health, Liberia
OTHER
Liberia Institute of Statistics and Geo-Information Services
UNKNOWN
Boston Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julia Rubin-Smith
Global Health Faculty/Assistant in Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julia Rubin-Smith, MD, MSPH
Role: PRINCIPAL_INVESTIGATOR
Boston Children's Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P00036604
Identifier Type: -
Identifier Source: org_study_id